focus
WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.
The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.
advertisement
The negotiated prices won’t take effect until 2026.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Readout Newsletter: Medeor's stem cell study, Moderna's stock dip
Next article： Activists slam private health insurers over coverage restrictions
Next article： Activists slam private health insurers over coverage restrictions
